Summary:
A multicenter, randomized, double blind 12 week, parallel group placebo controlled proof of concept study to investigate the efficacy and safety of RO5285119 individuals with Autism Spectrum Diorders.
Qualified Participants Must:
• Be male
•
Be between 18 and 45 years of age
•
Have a current diagnosis of Autism Spectrum Disorder
•
Speak English
•
Have a Caregiver
Qualified Participants May Receive:
Free medical evaluation, free study medication, compensation for time and travel for patient and caregiver.